China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$108B	$23 Million 2.57% of portfolio	49,419	Q3 2024 Added 41.78%
REGN Regeneron Pharmaceuticals, Inc.	$73.1B	$15.5 Million 1.74% of portfolio	14,766	Q3 2024 Added 54.62%
ALNY Alnylam Pharmaceuticals, Inc.	$30.3B	$10 Million 1.12% of portfolio	36,340	Q3 2024 Added 37.09%
MRNA Moderna, Inc.	$13.3B	$5.32 Million 0.6% of portfolio	79,611	Q3 2024 Added 67.63%
ARGX Argenx Se	$35.4B	$3.35 Million 0.37% of portfolio	6,174	Q3 2024 Added 64.03%
UTHR United Therapeutics Corp	$16.3B	$3.07 Million 0.34% of portfolio	8,557	Q3 2024 Added 64.15%
SMMT Summit Therapeutics Inc.	$3.58B	$3.05 Million 0.34% of portfolio	139,352	Q3 2024 Added 68.97%
BMRN Biomarin Pharmaceutical Inc	$11.4B	$2.6 Million 0.29% of portfolio	36,991	Q3 2024 Added 63.09%
NVO Novo Nordisk A S	$178B	$2.5 Million 0.28% of portfolio	21,000	Q3 2024 Added 5.0%
PCVX Vaxcyte, Inc.	$5.06B	$2.45 Million 0.27% of portfolio	21,466	Q3 2024 Added 67.95%
INCY Incyte Corp	$16B	$2.45 Million 0.27% of portfolio	37,043	Q3 2024 Added 40.23%
RPRX Royalty Pharma PLC	$13.4B	$2.44 Million 0.27% of portfolio	86,190	Q3 2024 Added 62.67%
INSM Insmed Inc	$9.82B	$2.41 Million 0.27% of portfolio	33,052	Q3 2024 Added 74.49%
SRPT Sarepta Therapeutics, Inc.	$10.3B	$2.29 Million 0.26% of portfolio	18,342	Q3 2024 Added 65.17%
BNTX Bio N Tech Se	$27.2B	$2.25 Million 0.25% of portfolio	18,939	Q3 2024 Added 63.28%
BGNE Bei Gene, Ltd.	$20.8B	$1.91 Million 0.21% of portfolio	8,510	Q3 2024 Added 69.39%
ASND Ascendis Pharma A/S	$7.15B	$1.66 Million 0.19% of portfolio	11,142	Q3 2024 Added 63.76%
ROIV Roivant Sciences Ltd.	$7.85B	$1.64 Million 0.18% of portfolio	142,234	Q3 2024 Added 63.88%
RVMD Revolution Medicines, Inc.	$3.53B	$1.46 Million 0.16% of portfolio	32,127	Q3 2024 Added 65.75%
EXEL Exelixis, Inc.	$11.7B	$1.42 Million 0.16% of portfolio	54,863	Q3 2024 Added 60.32%
HALO Halozyme Therapeutics, Inc.	$7.63B	$1.39 Million 0.16% of portfolio	24,364	Q3 2024 Added 62.94%
JAZZ Jazz Pharmaceuticals PLC	$7.6B	$1.32 Million 0.15% of portfolio	11,877	Q3 2024 Added 60.39%
CYTK Cytokinetics Inc	$4.31B	$1.19 Million 0.13% of portfolio	22,630	Q3 2024 Added 67.99%
NUVL Nuvalent, Inc.	$3.27B	$1.17 Million 0.13% of portfolio	11,417	Q3 2024 Added 64.39%
BPMC Blueprint Medicines Corp	$6.57B	$1.13 Million 0.13% of portfolio	12,183	Q3 2024 Added 65.64%
IONS Ionis Pharmaceuticals Inc	$4.46B	$1.13 Million 0.13% of portfolio	28,121	Q3 2024 Added 63.97%
RNA Avidity Biosciences, Inc.	$1.47B	$1.03 Million 0.12% of portfolio	22,526	Q3 2024 Added 100.5%
KRYS Krystal Biotech, Inc.	$3.81B	$1 Million 0.11% of portfolio	5,526	Q3 2024 Added 64.76%
RARE Ultragenyx Pharmaceutical Inc.	$2.8B	$984,000 0.11% of portfolio	17,726	Q3 2024 Added 81.51%
BBIO Bridge Bio Pharma, Inc.	$5.06B	$920,000 0.1% of portfolio	36,165	Q3 2024 Added 64.51%
ADMA Adma Biologics, Inc.	$3.27B	$896,000 0.1% of portfolio	44,829	Q3 2024 Added 64.61%
MDGL Madrigal Pharmaceuticals, Inc.	$4.67B	$886,000 0.1% of portfolio	4,176	Q3 2024 Added 66.77%
ACLX Arcellx, Inc.	$2.94B	$863,000 0.1% of portfolio	10,339	Q3 2024 Added 64.45%
AXSM Axsome Therapeutics, Inc.	$3.94B	$829,000 0.09% of portfolio	9,232	Q3 2024 Added 65.45%
DNLI Denali Therapeutics Inc.	$2.94B	$802,000 0.09% of portfolio	27,535	Q3 2024 Added 64.36%
CRNX Crinetics Pharmaceuticals, Inc.	$2.01B	$786,000 0.09% of portfolio	15,393	Q3 2024 Added 66.14%
IMVT Immunovant, Inc.	$3.55B	$774,000 0.09% of portfolio	28,151	Q3 2024 Added 64.05%
CRSP Crispr Therapeutics Ag	$3.16B	$769,000 0.09% of portfolio	16,381	Q3 2024 Added 64.2%
LEGN Legend Biotech Corp	$5.47B	$765,000 0.09% of portfolio	15,711	Q3 2024 Added 63.71%
DYN Dyne Therapeutics, Inc.	$765M	$693,000 0.08% of portfolio	19,310	Q3 2024 Added 67.94%
APLS Apellis Pharmaceuticals, Inc.	$3.29B	$675,000 0.08% of portfolio	23,420	Q3 2024 Added 64.24%
MRUS Merus N.V.	$1.82B	$655,000 0.07% of portfolio	13,119	Q3 2024 Added 68.56%
RYTM Rhythm Pharmaceuticals, Inc.	$3.05B	$616,000 0.07% of portfolio	11,758	Q3 2024 Added 64.15%
FOLD Amicus Therapeutics, Inc.	$2.64B	$609,000 0.07% of portfolio	57,044	Q3 2024 Added 63.92%
VRNA Verona Pharma PLC	$3.27B	$605,000 0.07% of portfolio	21,041	Q3 2024 Added 37.07%
KYMR Kymera Therapeutics, Inc.	$2.2B	$587,000 0.07% of portfolio	12,422	Q3 2024 Added 72.34%
XENE Xenon Pharmaceuticals Inc.	$2.4B	$573,000 0.06% of portfolio	14,572	Q3 2024 Added 64.32%
IOVA Iovance Biotherapeutics, Inc.	$933M	$548,000 0.06% of portfolio	58,376	Q3 2024 Added 77.56%
PTCT Ptc Therapeutics, Inc.	$3.14B	$548,000 0.06% of portfolio	14,795	Q3 2024 Added 64.17%
GERN Geron Corp	$1.1B	$526,000 0.06% of portfolio	115,937	Q3 2024 Added 66.38%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.